Koers Alternate Health Corp. Canadian Securities Exchange
Aandelen
AHG
CA02090B1022
Farmaceutische producten
Omzet 2017 | 13,25 mln. 9,65 mln. 9,02 mln. | Omzet 2018 | 577K 420K 393K | Marktkapitalisatie | 22,67 mln. 16,51 mln. 15,42 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -26 mln. -18,93 mln. -17,69 mln. | Nettowinst (verlies) 2018 | -24 mln. -17,47 mln. -16,33 mln. | EV/omzet 2017 | 6,25 x |
Nettoliquiditeiten 2017 | 893K 650K 607K | Nettoliquiditeiten 2018 | 773K 563K 526K | EV/omzet 2018 | 37,9 x |
K/w-verhouding 2017 |
-3,04
x | K/w-verhouding 2018 |
-0,76
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Mann
FOU | Founder | - | 11-12-18 |
Director of Finance/CFO | - | 25-01-18 | |
Chairman | - | 05-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James E. Tykoliz
BRD | Director/Board Member | - | 16-04-15 |
Chairman | - | 05-04-17 | |
Howard Mann
FOU | Founder | - | 11-12-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,48% | 5,8 mld. | |
-26,22% | 3,92 mld. | |
+4,73% | 3,28 mld. | |
-20,86% | 2,77 mld. | |
-11,88% | 2,26 mld. | |
+46,64% | 1,95 mld. | |
-16,71% | 1,52 mld. | |
+44,65% | 1,49 mld. | |
-9,60% | 1,49 mld. |